Preparation and properties of inhalable nanocomposite particles: Effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles

Colloids and Surfaces B: Biointerfaces

Volumn 64, Issue 1, 2008, Pages 70-76

  Tomoda, Keishiro ^a   Ohkoshi, Takumi ^a   Nakajima, Takehisa ^a   Makino, Kimiko ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Decomposition; FPF; Inhalation; Nanocomposite; Nanoparticle; PLGA; Spraydry

Indexed keywords

DECOMPOSITION; DEPOSITION; PARTICLE SIZE; PARTICLES (PARTICULATE MATTER); SPRAY DRYING; THERMAL EFFECTS;

AERODYNAMIC DIAMETERS; INHALATION; INLET TEMPERATURE; PRIMARY NANOPARTICLES; SPRAYDRY;

NANOCOMPOSITES;

NANOCOMPOSITE; NANOPARTICLE; POLYGLACTIN; RIFAMPICIN;

ANALYTIC METHOD; ARTICLE; DECOMPOSITION; DRUG DELIVERY SYSTEM; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SYNTHESIS; TEMPERATURE;

ADMINISTRATION, INHALATION; AEROSOLS; ANTIBIOTICS, ANTITUBERCULAR; LACTIC ACID; NANOCOMPOSITES; NANOPARTICLES; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POLYGLYCOLIC ACID; RIFAMPIN; TEMPERATURE;

EID: 43049085459     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2008.01.016     Document Type: Article

References (19)

1. Ammoury N., Dubrasquet M., Fessi H., Devissaguet J.-P., Puisieux F., and Benita S. Clin. Mater. 13 (1993) 121-130
2. Panyam J., and Labhasetwar V. Adv. Drug Delivery Rev. 55 3 (2003) 329-347
3. Zeng X.M., Martin G.P., and Marriott C. Int. J. Pharm. 124 (1995) 149-164
4. Sharma S., White D., Imondi A.R., Placke M.E., Vail D.M., and Kris M.G. J. Clin. Oncol. 19 (2001) 1839-1847
5. R. Dhand, Future directions in aerosol therapy, 7 (2001) 319-335.
6. Schürch S., Gehr P., Hof V.I., Geiser M., and Green F. Respir. Physiol. 80 (1990) 17-32
7. Pnayan J., Zhou W.Z., Prabha S., Sahoo S.K., and Labhasetwar V. FASEB J. 16 (2002) 1217-1226
8. Ghirardelli R., Bonasoro F., Porta C., and Cremaschi D. Biochim. Biophys. Acta: Biomembr. 12 (1999) 1-2
9. Huang M., Ma Z., Khor E., and Lim L.Y. Pharm. Res. 19 (2002) 1488-1494
10. Russell-Jones G.J., Veitch H., and Arthur L. Int. J. Pharm. 190 (1999) 165-174
11. Makino K., Nakajima T., Shikamura M., Ito F., Ando S., Kochi C., Inagawa H., Soma G.-I., and Terada H. Colloids Surf. B: Biointerf. 36 (2004) 35-42
12. K. Makino, H. Terada, T. Nakajima, K. Tomoda, JP075335 (March 17, 2006).
13. K. Tomoda, T. Ohkoshi, Y. Kawai, M. Nishiwaki, T. Nakajima, K. Makino, Colloids Surf. B: Biointerf., in press.
14. Bosquillon C., Lombry C., Preat V., and Vanbever R. J. Control. Release 70 (2001) 329-339
15. Zeng X.-M., MacRitchie H.B., Marriott C., and Martin G.P. Int. J. Pharm. 333 (2007) 45-55
16. Sham J.O.H., Zhang Y., Finlay W.H., Roa W.H., and Lobenberg R. Int. J. Pharm. 269 (2004) 457-467
17. Tomoda K., Kojima S., Kajimoto M., Watanabe D., Nakajima T., and Makino K. Colloids Surf. B: Biointerf. 45 (2005) 1-6
18. Tagne P.T., Briancon S., and Fessi H. Eur. J. Pharm. Sci. 30 (2007) 124-135
19. Freitas C., and Muller R.H. Eur. J. Pharm. Biopharm. 46 (1998) 145-151